Home | Back to newsletter main page

Bookmark and Share
Case Comprehensive Cancer Center Newsletter

January 7, 2013

CASE CCC IN THE NEWS

Salon Group Targets Tanning 'Myths'
ABC News - Jan 6, 2013
... they say it, according to Cleveland dermatologist Kevin Cooper, MD. ... and that is simply untrue," said Cooper, of Case Western Reserve ...

Secretary of State Clinton Remains Hospitalized for Blood Clot
MSNBC - Dec 31, 2012
Dr. Alvin Schmaier, hematologist with UH Case Medical Center, discusses blood clot dangers, and why Secretary Clinton may be at risk and how ...

Woman's Faith and Love of Family Help her Overcome Cancer
The Vindicator - Dec 23, 2012
Sometimes that is the only option, said Dr. Samuel T. Chao of the Cleveland Clinic's Brain Tumor and Neuro-oncology Center and Radiation Oncology Department...

Novel Assay Shows Promise in Heparin-induced Thrombocytopenia
Helio/HemOnc Today - Dec 21, 2012
Perspective commentary by Keith McCrae...This is an important study. Heparin-induced thrombocytopenia (HIT) is another major concern of hematologists...

Researcher Spotlights Changes in Treatment of ALL
Helio/HemOnc Today - Dec 20, 2012 (video)
Matt Kalaycio, MD, director of the Bone Marrow Transplant Program at Taussig Cancer Institute at Cleveland Clinic, reacts to the findings of two studies that addressed the role of autologous vs. allogeneic transplantation in patients with acute lymphoblastic leukemia.

Fibulin-3 Biomarker May Detect Early-stage Pleural Mesothelioma
Helio/HemOnc Today - Dec 18, 2012
Perspective commentary by James P. Stevenson... This study is important in that it describes the first highly-sensitive and specific plasma and pleural effusion biomarker for pleural mesothelioma...


ANNOUNCEMENTS

Kurt Stange To Lead Patient-Centered Outcomes Research Institute Research Project

Dr. Kurt Stange will lead a project funded by the Patient-Centered Outcomes Research Institute. The project will compare how focusing on patient strengths and patient-centered treatment can enhance patient health care and well-being as opposed to the usual model of focusing on the patient's symptoms, limitations and weaknesses. The project is part of a portfolio of patient-centered comparative clinical effectiveness research that addresses PCORI's National Priorities for Research and Research Agenda. [more]

Seidman Cancer Center Clinical Trials Unit Celebrate New Office Space

The University Hospitals Seidman Cancer Center (SCC) recently sponsored an open house event to celebrate the grand opening of new offices for the Clinical Trials Unit (CTU). The administrative offices of the SCC CTU have been relocated to the Fenway Manor building on the corner of Stokes Boulevard and Euclid Avenue.

This refurbished physical space consists of more than 6000 square feet, and brings together more than 50 employees who were previously dispersed. As Case CCC Associate Director for Clinical Research Dr. Neal Meropol notes, "The open style of architecture of this state-of-the-art facility was designed to encourage a high level of interaction and teamwork. I'm especially fond of the comfortable window seat for informal meetings." The newly redesigned space includes office and meeting space, and research chart storage space on site for the administrative, management, regulatory, data and clinical staff. The new offices will supplement our existing clinical and administrative space in the Seidman Cancer Hospital.

Parking is available at the Walker Building, across the street from new location. Access to the building is provided through the main entrance to Fenway Manor on Stokes Blvd. and contacting the research staff via the intercom system, or by directly contacting Melissa Kadar, Director Clinical Trials Unit.

CTSC Core Utilization Awards

Congratulations to the recipients of the September and October CTSC Core Utilization Awards (Case CCC members indicated in bold):

  • Mukesh Jain, MD: Circadian regulation of cardiac response to stress: a transcriptome study of cardiac KLF15 null mice
  • Neelesh Sharma, MD, PhD: Microarray gene expression analyses to identify pharmacodynamic marker of erlotinib and quinacrine in non-small cell lung cancer (NSCLC)
  • Erica Campagnaro, MD: Oncology Nurses' Barriers to Discussion of Clinical Trial Therapy with Cancer Patients - Qualitative Analyses and Instrument Development
  • Donna Hansel, MD, PhD: Development of a Bladder Cancer Urine Biomarker Core Utilization Pilot Grant
  • David Kennedy, PhD: Paraoxonases in Cardio-Renal Syndrome
  • Derek Taylor, PhD: Promoting cancer cell death by selective induction of telomere instability
  • Lance Vernon, DMD, MPH: Immune and Inflammatory Consequences of Intensive Periodontal Disease Treatment in HIV+ Adults

For more information on the CTSC and CTSC Pilot Funding Opportunities, please contact ctsc-research-concierge@case.edu.


FUNDING OPPORTUNITIES/AWARDS

Children's Tumor Foundation Young Investigator Award

The Children's Tumor Foundation is proud to announce the launch of the 2013 Young Investigator Award (YIA) application process. The Foundation's longest running program, YIA provides two-year awards for young scientists early in their careers, bringing them into the NF field and helping to establish them as independent investigators.

Pre-Application Deadline: January 25
Application Deadline: March 15

American Cancer Society IRG Awards

The Case CCC, with funds from its American Cancer Society Institutional Research Grant, will provide seed money to foster cancer research by junior faculty who have no current national grant support of their own. Investigators in the CWRU School of Medicine and Cleveland Clinic Lerner College of Medicine as well as in other schools and colleges in the University are eligible. Grants, not to exceed $30,000, will be awarded to investigators who intend to gather preliminary data to be used in seeking future and independently funded programs.

LOI Deadline: February 18
Application Deadline: April 5


MARK YOUR CALENDARS

OnCore Clinical Trials Management System Training Classes

OnCore training classes will be held quarterly at 12 pm in Wearn 137. Each class will cover a different topic in the OnCore database, with the last 15-20 minutes of each class open to answer specific questions. Participation is open and encouraged for anyone new or old to OnCore. Please feel free to bring your lunch. Webinar instructions will be sent prior to the class for those that cannot attend in person. One-on-one training sessions are also available as needed.

Schedule of sessions:

  • January 16, 2013: What We Learned About Missing Info in OnCore Needed for the Grant Renewal and NCI Site Visit (Including changes to the PRMC application)
  • April 17, 2013: Important Fields Needed for Clinicaltrials.gov and NCI/CTRP Registration (Including changes to the PRMC application)
  • July 17, 2013: Important Fields Needed for Clinicaltrials.gov Results Reporting
  • Oct 16, 2013: OnCore and CIRB Studies

Please contact April Firstencel at 216.286.2294 or april.firstencel@case.edu with any questions.

Prostate Cancer Symposium

The Glickman Urological & Kidney Institute, Lerner Research Institute, and Case Comprehensive Cancer Center invite you to a symposium on The Role of Interferon in Metastasis and Resistance to DNA Damage in Prostate Cancer, February 7 in Cleveland Clinic Room Q1-300. Registration information will be posted soon.

EVENTS

calendar

January 7

Cancer Center Research Chalk Talk
Sanford Markowitz, MD, PhD
Professor, Div. of Hem/Onc
CWRU/UH
Topic: TBD
12 pm WRB 3-136


January 8

Cancer Biology Fellows Seminar
Arindam Chakrabarti, PhD
Research Fellow, Silverman Lab, Cancer Biology
Cleveland Clinic
Topic: Immunoregulatory and Tumor Suppressor Functions of RNase L
11 am NC1-202 Cleveland Clinic

Immunology Seminar Series
Protul Shrikant, PhD
Professor, Immunology
Roswell Park Cancer Institute
Topic: Regulating mTOR to tune CD8+ T cell functional fate and tumor immunity
12 pm WRB 1-413

Medicine Grand Rounds
Saul Genuth, MD
Professor, Endocrinology
CWRU/UH
Topic: Treating Type 2 Diabetes in 2013
12 pm Kulas Auditorium, Lakeside 5th Fl.


January 9

Hematology and Oncology Division Research Conference
Cheng-Kui Qu, MD, PhD
Associate Professor, Div. of Hem/Onc
CWRU/UH
Topic: Targeting SHP2 (PTPN11) phosphatase for the treatment of childhood leukemias
8 am Lerner Tower B-151

Immunology Students/Fellows Research in Progress Seminar Series
Junjie Zhao
Graduate Student, Li Lab
Cleveland Clinic
Topic: The Molecular Mechanism of SIGIRR Mediated Tumor Suppression
AND
Hsiao Hsuan Kuo
Graduate Student, Baldwin Lab
Topic: Targeting Mediators of Antibody-Mediated Rejection
12 pm NC1-202 Cleveland Clinic


January 10

 


January 11

Taussig Cancer Institute Grand Rounds canceled

Hematology/Oncology Fellows Conference/Curriculum Series
Topic: TBD
8 am Wearn 137

Cancer Center Seminar Series
Andrew T. Chan, MD, MPH
Associate Professor, Medicine
Dana-Farber/Harvard Cancer Center
Topic: Aspirin for the Prevention and Treatment of Cancer
12 pm BRB 105

Cancer Center Research in Progress
Duncan Stearns, MD
Assistant Professor, Pediatrics-Hem/Onc
CWRU/UH
Topic: Expression of Tumor-derived Matrix Genes is Important for Growth in Medulloblastoma
4 pm WRB 3-136

 

 

Case CCC Calendar

LRI Calendar


UPCOMING CANCER CENTER SYMPOSIUMS & EVENTS

The Role of Interferon in Metastasis and Resistance to DNA Damage in Prostate Cancer
February 7
Cleveland Clinic Room Q1-300
Agenda

IMPACT: Improving Sickle Cell Patient Adherence Through Collaborative Teaching
March 23
Wolstein Research Building

Breast Cancer Conference
May 17
Hilton Cleveland East

 

ADDITIONAL UPCOMING SEMINARS & EVENTS

16th Annual Meeting of the Translational Research Cancer Centers Consortium (TRC3): The Power of Negative Thinking: Inhibiting the Inhibitors of Tumor Immunity
February 20-22
Seven Springs Mountain Resort, Seven Springs, PA
Details

National GvHD Health Symposium
November 1


PREVIOUSLY ANNOUNCED OPPORTUNITIES

AACR-Millennium Fellowship in Lymphoma Research
Deadline: January 7

AACR-Millennium Fellowship in Prostate Cancer Research
Deadline: January 7

Society of Surgical Oncology Clinical Investigator Awards
Deadline: January 7

2013 CTSC Annual Pilot Grant Funding
LOI Deadline: January 15

Caring for Carcinoid Foundation-AACR Grant for Carcinoid Tumor and Pancreatic Neuroendocrine Tumor Research
Deadline: January 15

Landon Foundation-AACR INNOVATOR Award for Research in Personalized Cancer Medicine
Deadline: January 15

Landon Foundation-AACR INNOVATOR Award for International Collaboration in Cancer Research
Deadline: January 23

Limited Submission: Samuel Waxman Cancer Research Foundation Individual Research Proposals
Internal Deadline: January 25
External Deadline: March 18

Sarcoma Foundation of America
Deadline: January 31

National Research Council Associateship Programs
Deadline: February 1

Oncology Nursing Society Foundation Master's Degree Scholarships
Deadline: February 1

Oncology Nursing Society Foundation Doctoral Degree Scholarships
Deadline: February 1

Prostate Cancer Foundation 2013 Young Investigator Awards
Deadline: February 1

Avon Foundation 2013 Breast Cancer Research Program
LOI Deadline: February 4
Invited Full Proposal Deadline: April 1

Leukemia and Lymphoma Society Translational Research Program
LOI Deadline: March 1
Full Application Deadline: March 15

Childhood Brain Tumor Foundation
Deadline: March 12

Translational Technology Concept Studies of Circulating Tumor and Endothelial Cells (CTC/CEC)
Deadline: Open

AACR Scholar-in-Training Awards - Other Conferences and Meetings
Deadline: Open

Case CCC Protocol Specific Research Support (PSRS)
Deadline: Open

International Union Against Cancer (UICC) International Cancer Technology Transfer Fellowships
Application Deadline: Open

International Waldenstrom's Macroglobulinemia Foundation (IWMF) Research Grant Program
Application Deadline: Open

James S. McDonnell Foundation Collaborative Activity Awards
Deadline: Open

NCI Short-Term Scientist Exchange Program
Application Deadline: Open

SAIC-Frederick Support of the Cancer Genome Atlas Program
Application Deadline: Open

Solving Kids' Cancer Therapeutic Development Initiative
Application Deadline: Open


NIH BULLETIN – Notices and Funding Opportunities

NIH Revision Applications for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (P30)(RFA-OD-12-007)

Changes to the NIH Public Access Policy and the Implications to Awards: Webinar - January 15, 2013 (NOT-OD-13-016)

Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20)(PAR-13-068)

Administrative Supplements to NCI-Funded Research Projects: Funding to Advance Research on Cancers in Women (Admin Supp)(PAR-13-067)

Notice of Intent to Publish a Funding Opportunity Announcement (FOA) for Dissemination and Implementation Research in Health (R01)(NOT-MH-13-009)

NIH Revision Applications for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (P30)(RFA-OD-12-007)

Limited Competition: Initiative to Maximize Research Education in Genomics (R25): Diversity Action Plan (PAR-13-063)

Cancer Prevention Research Small Grant Program (R03)(PAR-11-079)

Produced by:
Gillian Irwin Todd
11100 Euclid Avenue, Wearn 149
Cleveland, Ohio 44106-5065
216.844.8317 phone
216.844.7832 fax
gillian.irwin@case.edu

HELP US HELP YOU!

If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!

Send items to gillian.irwin@case.edu.